Chapter 26. Other Drug-Induced Dyskinesias

  1. Mark Hallett3 and
  2. Werner Poewe4
  1. Oscar S. Gershanik Scientific Director Director1,2

Published Online: 29 OCT 2008

DOI: 10.1002/9780470713990.ch26

Therapeutics of Parkinson's Disease and Other Movement Disorders

Therapeutics of Parkinson's Disease and Other Movement Disorders

How to Cite

Gershanik, O. S. (2008) Other Drug-Induced Dyskinesias, in Therapeutics of Parkinson's Disease and Other Movement Disorders (eds M. Hallett and W. Poewe), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470713990.ch26

Editor Information

  1. 3

    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

  2. 4

    Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

Author Information

  1. 1

    Department of Neurology-Centro Neurologico-Hospital Frances, Institute for Neuroscience, Fundacion Favaloro, ININFA-CONICET, Buenos Aires, Argentina

  2. 2

    Department of Neurology-Centro Neurologico-Hospital Frances, Laboratory of Experimental Parkinsonism, ININFA-CONICET, Buenos Aires, Argentina

Publication History

  1. Published Online: 29 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470066485

Online ISBN: 9780470713990

SEARCH

Keywords:

  • drug induced;
  • dyskinesia;
  • management;
  • anti epileptic;
  • anti depressant;
  • anti histamine;
  • psychostimulant;
  • sympathomimetics;
  • antibiotic;
  • immunosuppressants

Summary

This chapter contains sections titled:

  • Introduction

  • Drugs Involved in the Production of Dyskinesias

  • Principles of Management

  • References